These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 8843902

  • 21. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity.
    Valentovic MA, Elliott CW, Ball JG.
    Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):27-39. PubMed ID: 2829328
    [Abstract] [Full Text] [Related]

  • 22. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione.
    Kern TS, Kowluru RA, Engerman RL.
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2962-7. PubMed ID: 8206713
    [Abstract] [Full Text] [Related]

  • 23. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J.
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
    [Abstract] [Full Text] [Related]

  • 24. Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats.
    Ku DD, Meezan E.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):664-70. PubMed ID: 6144789
    [Abstract] [Full Text] [Related]

  • 25. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
    van Dijk DJ, Boner G, Giler S, Erman A.
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
    [Abstract] [Full Text] [Related]

  • 26. Nitric oxide decreases renal medullary Na+, K+-ATPase activity through cyclic GMP-protein kinase G dependent mechanism.
    Bełtowski J, Marciniak A, Wójcicka G, Górny D.
    J Physiol Pharmacol; 2003 Jun; 54(2):191-210. PubMed ID: 12832721
    [Abstract] [Full Text] [Related]

  • 27. Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats.
    Tsimarato M, Coste TC, Djemli-Shipkolye A, Daniel L, Shipkolye F, Vague P, Raccah D.
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):239-45. PubMed ID: 11354996
    [Abstract] [Full Text] [Related]

  • 28. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
    Zhang JZ, Xi X, Gao L, Kern TS.
    Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
    Wu Y, Ouyang JP, Zhou YF, Wu K, Zhao DH, Wen CY.
    Sheng Li Xue Bao; 2004 Aug 25; 56(4):539-49. PubMed ID: 15322693
    [Abstract] [Full Text] [Related]

  • 30. Differential effect of omega3 PUFA supplementations on Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratio.
    Djemli-Shipkolye A, Raccah D, Pieroni G, Vague P, Coste TC, Gerbi A.
    J Membr Biol; 2003 Jan 01; 191(1):37-47. PubMed ID: 12532275
    [Abstract] [Full Text] [Related]

  • 31. Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
    Kamata K, Mizutani K.
    Res Commun Mol Pathol Pharmacol; 1999 Jan 01; 104(2):181-92. PubMed ID: 10634311
    [Abstract] [Full Text] [Related]

  • 32. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
    Bursell SE, Takagi C, Clermont AC, Takagi H, Mori F, Ishii H, King GL.
    Invest Ophthalmol Vis Sci; 1997 Dec 01; 38(13):2711-20. PubMed ID: 9418723
    [Abstract] [Full Text] [Related]

  • 33. Tissue-specific regulation of angiotensin-converting enzyme by angiotensin II and losartan in the rat.
    Metsärinne KP, Helin KH, Saijonmaa O, Stewen P, Sirviö ML, Fyhrquist FY.
    Blood Press; 1996 Nov 01; 5(6):363-70. PubMed ID: 8973755
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.
    Adam A, Leclair P, Montpas N, Koumbadinga GA, Bachelard H, Marceau F.
    Neuropeptides; 2010 Apr 01; 44(2):69-75. PubMed ID: 19836835
    [Abstract] [Full Text] [Related]

  • 36. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M, Freel RW, Shahinfar S, Vaziri ND.
    J Pharmacol Exp Ther; 1996 Jan 01; 276(1):187-93. PubMed ID: 8558429
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Angiotensin II directly stimulates activity and alters the phosphorylation of Na-K-ATPase in rat proximal tubule with a rapid time course.
    Yingst DR, Massey KJ, Rossi NF, Mohanty MJ, Mattingly RR.
    Am J Physiol Renal Physiol; 2004 Oct 01; 287(4):F713-21. PubMed ID: 15161602
    [Abstract] [Full Text] [Related]

  • 40. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production.
    Hajnóczky G, Csordás G, Hunyady L, Kalapos MP, Balla T, Enyedi P, Spät A.
    Endocrinology; 1992 Mar 01; 130(3):1637-44. PubMed ID: 1311245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.